Skip to content
Screener

Rapid Micro Biosystems RPID Q3 2025 earnings

Reported November 7, 2025 · Before market open

Revenue$7.8MMiss by $3.1M
EPS-$0.26In line
Revenue estimate$10.9M
EPS estimate-$0.26

Next report

Nov 6, 2026 (in 2 months)
Revenue estimate$10.0M
EPS estimate-$0.19

Financials

Q3 2025

Income statement

See full
Revenue$7.8M+3.1%
Operating income-$11.4M+5.5%
Net income-$11.5M-1.6%
EPS (diluted)-$0.260.0%

Balance sheet

See full
Cash & equivalents$19.2M-13.9%
Total debt$24.2M+272%
Total equity$44.3M-47.5%
Total assets$84.4M-20.3%

Cash flow

See full
Operating cash flow-$9.1M-5.2%
CapEx$73.0K-67.3%
Free cash flow-$9.1M-3.4%

Valuation & ratios

Valuation

as of 09/30/25
See full
Market cap$147.66M+287%
Enterprise value$152.59M+582%
P/S4.8×+3.4×

Profitability

See full
Operating margin-148.8%-29.7pp
Net margin-145.1%-25.7pp
FCF margin-126.4%-27.0pp

Returns & leverage

See full
Return on equity-68.8%+71.3pp
Debt / equity0.5×+0.5×
Current ratio4.2×-1.3×

Segments

By product

See full
Service$2.6M+11.7%

FAQ

When did Rapid Micro Biosystems report Q3 2025 earnings?
Rapid Micro Biosystems (RPID) reported Q3 2025 earnings on November 7, 2025 before market open.
What were Rapid Micro Biosystems's Q3 2025 revenue and EPS?
Rapid Micro Biosystems reported revenue of $7.8M and eps of $-0.26 for Q3 2025.
Did Rapid Micro Biosystems beat estimates in Q3 2025?
Revenue missed the consensus estimate of $10.9M by $3.1M. EPS beat the consensus estimate of $-0.26 by $0.00.
How did Rapid Micro Biosystems's Q3 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 3.1% from $7.6M a year earlier and eps grew 0.0% from $-0.26.
Where can I find Rapid Micro Biosystems's Q3 2025 SEC filings?
You can read the 8-K earnings release (0001380106-25-000195) and the 10-Q periodic report (0001380106-25-000200) directly on SEC EDGAR. The filing index links above go to sec.gov.